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SYNOPSIS 
Cells invest a lot of energy in order to get their proteins to fold correctly and attain 
functionality. It is the functional proteome of a cell that defines the ‘life of a cell’. Cells 
have therefore employed dedicated machinery called chaperones to enable protein 
folding. One class of these chaperones is heat shock proteins named so because they were 
initially discovered to be heat inducible and particularly important during heat stress. 
However the role of heat shock proteins has now been extended from merely being 
important for stress tolerance. Heat shock proteins are prominently involved in 
maintaining the correct folding and conformation of proteins and are vital in regulating 
the stability between protein synthesis and degradation.  
One of the heat shock proteins, Hsp90, is an evolutionarily conserved molecular 
chaperone essential in all known eukaryotes examined so far. Unlike other chaperones, 
Hsp90 is unique in binding to substrate proteins, which are at a late stage of folding, 
poised for activation by either ligand binding or interaction with other cellular factors. 
The most common clients of Hsp90 are signaling proteins, the classic example being 
steroid hormone receptors and signaling kinases. Several other proteins including 
transcription factors, proteins involved in cell division and development have also been 
shown to rely on Hsp90 functioning for their maturation. Hsp90 has emerged as an 
important molecular chaperone due to the large number of proteins that depend on the 
activity of Hsp90 for their functionality. Hsp90 plays a central role in multiple cellular 
processes. Since knock-out of hsp90 is lethal to most eukaryotes, inhibitors of Hsp90 
have been widely used to study its function. The most widely used inhibitor is 
geldanamycin (GA). GA binds to the N-terminal/ATP binding site of Hsp90 which 
results in the degradation of client proteins.  
Hsp90 clients have been shown to be proteins important for diverse cellular processes 
such as protein trafficking, signal transduction, cell-cycle, cellular motility and 
development in eukaryotes. Exploring new Hsp90 clients gives an insight into more 
pathways that Hsp90 regulates. Intriguingly, many proteins interact with Hsp90 in a 
context dependent manner, i.e., under certain environmental cue, or in a particular tissue, 
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or only under certain diseased states. It is therefore essential to study Hsp90 functioning 
and examine Hsp90-client interactions in more than one model organism.  
Dictyostelium discoideum: a model organism to study the role of Hsp90 in 
development 
The eukaryote, Saccharomyces cerevisiae that has been explored extensively for studying 
the diverse clientele of Hsp90, lacks various signaling pathways important for growth and 
differentiation as prevalent in higher eukaryotes.  It is desirable to develop a model 
system that would combine the advantages of a lower eukaryote, in terms of its ease of 
manipulation and retain the complexities of higher eukaryotes. With this motivation, the 
social slime mold D. discoideum was explored to examine potential roles of cytoplasmic 
Hsp90 in growth and development.  
D. discoideum is ideal for studying signaling pathways important for growth and 
differentiation and to understand how these pathways control cellular responses to 
external stimuli. Multicellular development in D. discoideum occurs in response to 
starvation induced stress. As in case of many other protozoans, we conjectured that 
Hsp90 may participate in regulating developmental transition from unicellular to 
multicellular stages in Dictyostelium as well. My initial study attempts, to address the 
role of Hsp90 (HspD), in development of D. discoideum. Towards this two approaches 
were taken: through genetic interference of HspD, and the other, through its 
pharmacological inhibition. An antisense HspD plasmid was designed which upon 
transfection in D. discoideum, showed a very slow growth phenotype, and the cells did 
not survive beyond few generations. Therefore to further study the functions of HspD, I 
resorted to pharmacological inhibition by using the specific, well characterized inhibitor, 
GA. As a first step towards this I examined whether GA was capable of binding to HspD 
from D. discoideum cell lysate. Towards this, GA was immobilized to NHS-sepharose 
beads, and bound proteins were examined. Western blot of the bound fraction, using 
antibody specific to HspD, identified it as a predominant protein being pulled down. This 
was further confirmed by mass spectrometry. To be able to compare Hsp90 from D. 
discoideum with Hsp90s from other model organisms, HspD was cloned, purified and 
biochemically characterized. Comparison of ATPase activities of HspD with Hsp90’s 
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from other systems indicates HspD to possess a relatively low ATPase activity with a 
Kcat of 1.6 x 10-3 min-1. The dissociation constant of GA for HspD was found to be 0.8 
µM, which was in the range similar to Hsp90s from other systems. In addition, we have 
now obtained structural data on HspD in collaboration with crystallography groups. The 
N-terminal domain of HspD has been crystallized, both in -free and ligand-bound forms. 
Crystal structure comparison of HspD with Hsp90 from S. cerevisiae shows overall fold 
similarity yet some important differences in side chain orientations of specific residues in 
the ATP binding domain. 
Interestingly, on treating D. discoideum cells with GA or another Hsp90 N-terminal 
inhibitor, Radicicol, it was found that, while control cells progressed to develop into 
fruiting bodies, GA/Radicicol treated cells resulted in delayed development, and were 
finally arrested at the ‘mound’ stage. This suggested potential involvement of HspD in 
developmental progression beyond the mound stage. In order to identify the pathways 
that are probably affected by HspD in D. discoideum development, cells were treated 
with/without GA and subjected to comparative proteomics using mass spectrometric 
analysis. Amongst other differences, there was an obvious absence of peptides 
corresponding to the protein paxillin in GA treated cells. The results were verified by 
Western blot analysis, using a specific antibody against paxillin, wherein a drastic 
decrease in paxillin levels were observed in cells treated with GA. Paxillin is a key player 
in focal adhesion sites that functions as an adaptor protein to recruit diverse cytoskeletal 
and signaling proteins into a complex, and is essential for cellular proliferation and cell-
substrate adhesion. My studies suggest that one of the pathways through which HspD 
regulates development is through cellular motility as Hsp90 was involved in regulating 
proteins necessary for motility and cytoskeletal organization at focal adhesion points 
during development in D. discoideum.  
Hsp90 as a target for Trypanosoma evansi infections 
In addition to examining the role of Hsp90 in differentiation in D. discoideum, I have also 
looked at the potential of Hsp90 under diseased conditions. Towards this, I explored the 
protozoan parasite, T. evansi, which causes a fatal disease ‘surra’. Surra is a neglected 
disease that mainly affects domestic and wild animals including equines, camels, cattle 
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and buffaloes. The parasite causes significant economic losses to livestock industry. 
While this infection is mainly restricted to domestic (camels, equines, cattle, buffaloes, 
goats, sheep, pigs, dogs etc.) and wild animals, recent reports indicate their ability to 
infect humans. There are no reliable sensitive and specific diagnostic tests or vaccines 
available against this disease and the available drugs show significant toxicity. There is 
an urgent need to develop improved methods of diagnosis and control measures for this 
disease. Unlike its related human parasites T. brucei and T. cruzi whose genomes have 
been fully sequenced T. evansi genome sequence remains unavailable. With a view to 
identifying potential diagnostic markers and drug targets I have studied the clinical 
proteome of T. evansi infection using mass spectrometry. I have been able to identify 
almost 166 proteins of T. evansi, which also included potential drug and vaccine targets. 
Due to absence of any genome sequence information from T. evansi, most of the peptides 
obtained matched to its related species, T. brucei, T. cruzi and also few from Leishmania 
major. Importantly, I was also able to identify peptides from Hsp90. Hsp90 from T. 
evansi was cloned and its sequence was also obtained. 
To investigate the possibility of exploring Hsp90 as a target against Surra infections, 
TeHsp90 protein was purified by expressing it in bacterial cells, and its drug (GA) 
binding ability was examined in-vitro. The dissociation constant of GA for HspD was 
found to be 1.4 µM, which was in the range similar to Hsp90s from other systems. The 
ability of 17AAG (a derivative of GA) was examined in inhibiting T. evansi infection at 
pre-clinical level.  Towards this, swiss female mice were infected with purified parasites 
and then the drug was injected either immediately, in one group of mice, and in another 
group of mice the parasites were challenged with the drug only after the onset of 
infection. Interestingly, both groups of mice were found to get cured using Hsp90 
inhibitor. The pre-clinical results suggested that Hsp90 was an interesting drug target and 
its inhibitor could indeed be used against ‘surra’ infections. 
Hsp90 from Giardia lamblia: An unusual case 
Hsp90 was also examined from another pathogenic protozoan, Giardia lamblia, one of 
the leading causes of diarrhea in the world. Previous studies from our lab have shown 
Gardial Hsp90 to be coded by two different ORFs, spliced together in trans. This is 
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indeed the only example of trans-splicing in Hsp90 known so far. My study further 
characterizes this finding through analysis of transcription levels of the individual ORFs, 
using Northern blot analysis. Importantly, I was able to detect transcripts of all three 
forms of Hsp90; full-length, N terminus as well as C terminus, suggesting that these are 
expressed and may have biological significance. To understand the significance of these 
independent transcripts, I have examined relative levels of expression of all three forms 
by Real-time PCR analysis wherein there was almost 90 fold and 5 fold lesser transcript 
level of N terminus and C terminus Hsp90 observed, respectively as compared to the full-
length GlHsp90 expression. Previous reports have shown Hsp90 from all known 
organisms, to get up regulated during heat shock. Thus it was important to examine the 
effect of heat stress on the expression of these independent transcripts. Interestingly, 
different domains were found to get independently induced during heat stress. The 
transcript level of HspC was seen to be almost similar to that of full-length upon heat 
shock. There was also a significant up regulation observed in HspN transcript upon heat 
shock. Taking together all these observations, these results suggest a possible role for the 
independent domains, HspN and HspC during heat stress in G. lamblia. Furthermore, I 
have cloned and purified one of the individually expressed domains, HspN and 
characterized it biochemically. HspN was found to be able to bind to ATP, however 
lacked ATPase activity. Taking together all these observations, it suggests a possible role 
for the independent domains, HspN and HspC which needs to be investigated further. 
Summary 
Altogether, my studies establish the importance of alternate model systems in 
understanding the biology of Hsp90. The importance of Hsp90 was first established in 
growth and development of a nonpathogenic protozoan D. discoideum.  My results 
provide significant insights into the additional pathways that Hsp90 regulates during D. 
discoideum development. One such important pathway was delineated to be cellular 
locomotion and motility.  
Further, I have also studied the importance of Hsp90 in neglected infectious diseases. In 
addition to providing a glimpse into the pathways operational during disease 
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manifestation in T. evansi, we have shown Hsp90 to be effective in pre-clinical trials 
against T. evansi infections. 
Hsp90 from another pathogenic protozoan, G. lamblia, has also been studied. This is by 
far the only organism, in which there is an independent expression of the N- and C-
terminal domain of Hsp90. The rare gene organization, coupled with independent 
expression of domains of Hsp90, makes this organism important to examine novel 
functions of this chaperone. 
